Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation01:24

Tissue Transplantation

1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Healthcare Agencies I01:18

Healthcare Agencies I

1.2K
Healthcare agencies provide healthcare services to people. In the United States, voluntary agencies are often non-profit centers sponsored by donations, grants, or fundraisers. One such organization is Meals on Wheels, which provides meals to the elderly and homebound. The American Heart Association and the American Lung Association are other non-profit community organizations. Doctors and nurses are frequently active members of these organizations, which offer health checks and educational...
1.2K
Batteries and Fuel Cells03:12

Batteries and Fuel Cells

24.1K
A battery is a galvanic cell that is used as a source of electrical power for specific applications. Modern batteries exist in a multitude of forms to accommodate various applications, from tiny button batteries such as those that power wristwatches to the very large batteries used to supply backup energy to municipal power grids. Some batteries are designed for single-use applications and cannot be recharged (primary cells), while others are based on conveniently reversible cell reactions that...
24.1K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Rehabilitation Utilization After CAR T-Cell Therapy.

Transplantation and cellular therapy·2026
Same author

Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

European journal of haematology·2026
Same author

Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.

Signal transduction and targeted therapy·2026
Same author

Faecal microbiota transplant for chronic norovirus infection: a case report of donor microbiota engraftment without clinical success.

Gastroenterology report·2026
Same author

Comprehensive Assessment of CD19 Immunohistochemical Staining in Classic Hodgkin Lymphoma.

The American journal of surgical pathology·2026
Same author

Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study.

Lancet (London, England)·2026
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

2.4K

Donating used CARs.

Aaron P Rapoport1

  • 1UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE;

Blood
|December 17, 2013
PubMed
Summary
This summary is machine-generated.

Engineered chimeric antigen receptor (CAR) T cells from donors can safely treat relapsed B-cell cancers after stem cell transplants. This CAR T-cell therapy offers a new option for patients with CD19-positive malignancies.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.3K

Related Experiment Videos

Last Updated: May 4, 2026

Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

2.4K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.3K

Area of Science:

  • Hematology
  • Immunotherapy
  • Oncology

Background:

  • Relapsed CD19-positive B-cell malignancies after allogeneic stem cell transplantation (allo-SCT) have limited treatment options.
  • Allogeneic CAR T-cell therapy presents a potential strategy to overcome graft rejection and disease relapse.

Purpose of the Study:

  • To evaluate the safety and efficacy of donor-derived allogeneic CD19-chimeric antigen receptor (CAR) T cells in patients with relapsed B-cell malignancies post-allo-SCT.

Main Methods:

  • The study involved patients with relapsed CD19-positive B-cell malignancies.
  • Treatment consisted of engineered allogeneic CD19-CAR T cells derived from healthy donors.
  • Patients had previously undergone allo-SCT.

Main Results:

  • The administration of allogeneic CD19-CAR T cells was found to be safe.
  • The treatment demonstrated efficacy in managing CD19-positive B-cell malignancies.
  • No significant adverse events related to graft-versus-host disease were reported.

Conclusions:

  • Donor-derived allogeneic CD19-CAR T-cell therapy is a safe and effective treatment for CD19-positive B-cell malignancies.
  • This approach provides a viable therapeutic option for patients who have relapsed after allo-SCT.